ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,909.03
      -1.11%
      US Tech 100
      20,670.40
      0.31%
      Dow Jones
      42,528.36
      -0.42%
      Brent Oil
      77.535
      0.62%
      Bitcoin
      96,040.44
      -0.89%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Microbot Medical Inc (MBOT)

      7. Microbot Medical Inc (MBOT) News

      MBOT

      Microbot Medical (MBOT)

      Microbot Medical Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MBOT
      DateTimeSourceHeadlineSymbolCompany
      1:35PMiHub NewswireFeaturedEzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion
      01/07/20254:15PMGlobeNewswire Inc.Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM FacilityNASDAQ:MBOTMicrobot Medical Inc
      01/07/20259:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      01/07/20258:45AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBOTMicrobot Medical Inc
      01/06/20255:25PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
      01/06/20255:25PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
      01/06/20258:00AMGlobeNewswire Inc.Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
      01/06/20257:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      12/30/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      12/30/20248:30AMGlobeNewswire Inc.Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®NASDAQ:MBOTMicrobot Medical Inc
      12/19/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      12/10/202410:18AMGlobeNewswire Inc.Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All AccessNASDAQ:MBOTMicrobot Medical Inc
      12/10/20248:05AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
      12/10/20248:05AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
      12/10/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      12/10/20248:00AMGlobeNewswire Inc.Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic SystemNASDAQ:MBOTMicrobot Medical Inc
      11/13/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MBOTMicrobot Medical Inc
      11/06/20249:02AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MBOTMicrobot Medical Inc
      11/06/20249:02AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MBOTMicrobot Medical Inc
      11/06/20249:00AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MBOTMicrobot Medical Inc
      10/31/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      10/15/20248:40AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
      10/15/20248:40AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
      10/15/20248:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      10/15/20248:38AMGlobeNewswire Inc.Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025NASDAQ:MBOTMicrobot Medical Inc
      10/11/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      10/01/20248:10AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
      10/01/20248:07AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
      09/30/20248:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
      09/30/20248:30AMGlobeNewswire Inc.Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow upNASDAQ:MBOTMicrobot Medical Inc
       Showing the most relevant articles for your search:NASDAQ:MBOT